Precision medicine for the brain is here. We are pioneering an approach to psychiatric drug development which matches the right patient with the right Alto drug based on AI-derived brain biomarkers.
We are redefining psychiatry with AI-driven brain biomarkers that align the right patient with the right Alto drug, leveraging the richest in-human data set specifically built for precision psychiatry. Our work builds on a decade of clinical neuroscience research.
With multiple medicines in our pipeline for mental health conditions, including depression and post-traumatic stress disorder (PTSD), we are moving swiftly to quickly identify the right patients for each drug and combat the spiraling mental health crisis.
